APA (7th ed.) Citation

Allegretti, J. R., Cheifetz, A. S., Dulai, P. S., Stevens, A., Chapas-Reed, J., Chesnel, L., . . . Gupta, R. (2023). S186 ADS051, an Oral, Gut-Restricted, Small Molecule Neutrophil Modulator in Patients With Moderate-To-Severe Ulcerative Colitis: Results From a Multiple Ascending Dose Study. American Journal of Gastroenterology (Lippincott Williams & Wilkins), 118, S141. https://doi.org/10.14309/01.ajg.0000950384.53651.0f

Chicago Style (17th ed.) Citation

Allegretti, Jessica R., et al. "S186 ADS051, an Oral, Gut-Restricted, Small Molecule Neutrophil Modulator in Patients With Moderate-To-Severe Ulcerative Colitis: Results From a Multiple Ascending Dose Study." American Journal of Gastroenterology (Lippincott Williams & Wilkins) 118 (2023): S141. https://doi.org/10.14309/01.ajg.0000950384.53651.0f.

MLA (9th ed.) Citation

Allegretti, Jessica R., et al. "S186 ADS051, an Oral, Gut-Restricted, Small Molecule Neutrophil Modulator in Patients With Moderate-To-Severe Ulcerative Colitis: Results From a Multiple Ascending Dose Study." American Journal of Gastroenterology (Lippincott Williams & Wilkins), vol. 118, 2023, p. S141, https://doi.org/10.14309/01.ajg.0000950384.53651.0f.